S.2503 - Preventing Superbugs and Protecting Patients Act114th Congress (2015-2016) |
| Sponsor: | Sen. Murray, Patty [D-WA] (Introduced 02/04/2016) |
|---|---|
| Committees: | Senate - Health, Education, Labor, and Pensions |
| Latest Action: | 04/05/2016 Placed on Senate Legislative Calendar under General Orders. Calendar No. 417. (All Actions) |
Tracker:
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Subject — Policy Area:
- Health
- View subjects
-
Summary (2)
-
Text (2)
-
Actions (4)
-
Titles (3)
-
Amendments (0)
-
Cosponsors (0)
-
Committees (1)
-
Related Bills (1)
Summary: S.2503 — 114th Congress (2015-2016)All Bill Information (Except Text)
Bill summaries are authored by CRS.
Shown Here:
Reported to Senate amended (04/05/2016)
Preventing Superbugs and Protecting Patients Act
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.
(Sec. 3) The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.